Categories: Ethereum

New partnership established to track drugs using blockchain

Click here to view original web page at

Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.

A spokesperson representing Walmart confirmed to CoinDesk that it has joined MediLedger, which, as stated on its website, is aiming to create an “open and decentralised network for the pharmaceutical supply chain,” designed to address the tightening regulations that govern the supply chains of drugs and medications.

According to the Drug Supply Chain Security Act from the Food and Drug Administration (FDA), pharmaceutical companies need to “build an electronic, interoperable system to identify and trace certain prescription drugs as they’re distributed in the United States.”

“As part of our ongoing efforts to protect our nation’s drug supply, we’re giving industry an opportunity to test new technologies that can help spur greater accountability for participants in the supply chain and improve our ability to trace prescription drugs at every point in the distribution chain,” said FDA Commissioner Scott Gottlieb on the launch of the FDA’s pilot programme for the tracing and verification of prescription drugs in the US in February this year.

Applying quality risk management to develop an isolator filling line

Following the patent of the innovative “Espresso” intravenous delivery device, the Italian Biochemical Institute (IBI) “Lorenzini” commissioned Comecer to construct a filling line to meet the unique requirements of the solution. Register for our on-demand webinar with industry experts to find out more.

As reported by Hard Fork, MediLedger is hoping its enterprise-oriented private fork of Ethereum will provide part of the solution for this.

With this news, Walmart joins a host of companies like Pfizer, McKesson Corporation, AmerisourceBergen, and Premier Inc that are all in the process of testing MediLedger.

This isn’t Walmart’s first foray into blockchain, however. With E. Coli outbreaks on the rise, last September Walmart began informing all of its leafy green suppliers that they would have to start tracking their produce on the blockchain within a year.

Whether the solution is blockchain or not, given the FDA’s regulations on the supply of drugs, pharmaceutical companies will certainly require a digital system to track and trace their delivery.


Illuminati, Mason, Anonymous I'll never tell. I can tell you this, global power is shifting and those who have the new intelligence are working to acquire this new force. You matter naught except to yourself, therefore prepare for the least expected and make your place in the new world order.

Disqus Comments Loading...
Published by

Recent Posts

Bitcoin Price Forecast: BTC/USD Volume Could Indicate A Breakout

Bitcoin’s daily volume spike could create a necessary condition for a breakout. Traded price ranges continue to constrict. Bitcoin’s Bullish… Read More

4 hours ago

Billionaire Tim Draper: Bitcoin Will Hit $250,000 By 2022

Billionaire venture capitalist Tim Draper told BlockTV that in the next several years, Bitcoin could reach $250,000 per coin. "$250,000… Read More

4 hours ago

Maduro Mandates Petro-Financed Public Housing Scheme in Venezuela

Embattled Venezuelan leader Nicolas Maduro looks to expand Petro adoption through a new housing initiative. | Image: REUTERS /THIRD PARTY.… Read More

4 hours ago

Malware InnfiRAT Targets Bitcoin And Crypto Wallets

The malware named InnfiRAT could be stealing bitcoins and cryptocurrency wallet information. It is usually downloaded through email attachments and… Read More

4 hours ago

Bitcoin (BTC) Interest in China Driven by Price Action News

Share Tweet Send Share Baidu search trends in 2019 show Chinese bitcoin interest being driven largely by price action news.… Read More

4 hours ago

Crypto and the Latency Arms Race: Crypto Exchanges and the HFT Crowd

Max Boonen is founder and CEO of crypto trading firm B2C2 . This post is the second in a series… Read More

4 hours ago

This website uses cookies. We use these cookies to collect data about your interaction with our website for the purpose of continuously improving your experience with our site. For more information we encourage you to read our privacy policy.

Read More